EJXB Stock Overview
A medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Elekta AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 5.26 |
| 52 Week High | SEK 7.80 |
| 52 Week Low | SEK 5.21 |
| Beta | 1.12 |
| 11 Month Change | -12.04% |
| 3 Month Change | -11.75% |
| 1 Year Change | -31.51% |
| 33 Year Change | -50.96% |
| 5 Year Change | -53.88% |
| Change since IPO | 144.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| EJXB | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -2.6% | -1.0% | -0.02% |
| 1Y | -31.5% | -7.3% | 8.2% |
Return vs Industry: EJXB underperformed the German Medical Equipment industry which returned -8.4% over the past year.
Return vs Market: EJXB underperformed the German Market which returned 7.4% over the past year.
Price Volatility
| EJXB volatility | |
|---|---|
| EJXB Average Weekly Movement | 4.9% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: EJXB has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: EJXB's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | 4,566 | Gustaf Salford | elekta.com |
Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit; Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Leksell GammaPlan, a treatment planning and management software.
Elekta AB (publ) Fundamentals Summary
| EJXB fundamental statistics | |
|---|---|
| Market cap | €2.10b |
| Earnings (TTM) | €98.61m |
| Revenue (TTM) | €1.58b |
21.3x
P/E Ratio1.3x
P/S RatioIs EJXB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EJXB income statement (TTM) | |
|---|---|
| Revenue | SEK 18.12b |
| Cost of Revenue | SEK 11.49b |
| Gross Profit | SEK 6.63b |
| Other Expenses | SEK 5.50b |
| Earnings | SEK 1.13b |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
Nov 27, 2024
| Earnings per share (EPS) | 2.97 |
| Gross Margin | 36.60% |
| Net Profit Margin | 6.26% |
| Debt/Equity Ratio | 60.6% |
How did EJXB perform over the long term?
See historical performance and comparisonDividends
3.8%
Current Dividend Yield81%
Payout RatioDoes EJXB pay a reliable dividends?
See EJXB dividend history and benchmarks| Elekta dividend dates | |
|---|---|
| Ex Dividend Date | Mar 06 2025 |
| Dividend Pay Date | Mar 12 2025 |
| Days until Ex dividend | 103 days |
| Days until Dividend pay date | 109 days |
Does EJXB pay a reliable dividends?
See EJXB dividend history and benchmarks